Search

everythinglearnresearchcommunity

for

Search:↓

Targeted radionuclide therapy shows promise for improving head and neck cancer treatment but needs more research.

Cell-mediated drug delivery systems improve skin disease treatment by using living cells for precise, prolonged, and less toxic therapy.

Platelet-rich plasma does not improve recovery after Achilles tendon surgery.

Using young Lokananta shallot seedlings at a specific density boosts yield and profits.

Pharmaceutical supply chains need stronger strategies and collaboration to ensure continuous medical product supply during pandemics.

The FDA approved the first gene therapy for a blood disorder after overcoming early challenges and demonstrating patient benefits.

Using scalp micropigmentation (a special tattoo technique) with hair transplantation can effectively treat hair loss, especially for those with low donor density or those unsuitable for only hair transplantation.

Alopecia areata causes significant financial strain and dissatisfaction with treatment in Norway and Sweden.

Alopecia areata in Saudi Arabia is costly, mainly due to lost productivity and drug costs.

Many are open to telemedicine for hair loss if combined with in-person visits and better technology.

Microneedles improve drug delivery for skin diseases, enhancing treatment effectiveness and patient compliance.

Drug repositioning is a promising way to quickly develop new treatments, especially for rare diseases.

Herbal hair gels are better for hair health than synthetic ones.

The buffy coat method yields higher TGF-β1 levels in PRP, especially in males.

The critique highlights an error in a review about hair loss treatment, stressing the need for accurate information and caution due to poor evidence quality.

The TPAP method effectively categorizes androgenetic alopecia patients with high accuracy, but needs real-world validation.

Patients with advanced breast cancer prioritize quality of life, overall survival, and progression-free survival in treatment decisions.

Patients and doctors often differ in assessing hair loss severity, so treatment should be personalized.

Finasteride may be linked to Peyronie’s disease, but more research is needed.

Hyperbaric oxygen therapy shows promise for multiple sclerosis, but skepticism and funding issues limit tech use in clinics, and outdated single-drug cancer treatments may cause unnecessary side effects.

Real-life dosing of biologics for plaque psoriasis often deviates from recommended guidelines, especially for high-need patients.

BPH management needs better long-term studies and prevention strategies.

A new method improves the accuracy and reliability of language models by up to 42%.

Some people have a genetic variation that makes them less effective at breaking down drugs.

Misdiagnosis of hair and scalp disorders is common in patients with skin of color, highlighting the need for better training and evaluation.

People's decision-making can be influenced by their internal biological clocks, as shown by gene expression, not just self-reported preferences for morning or evening.

The revised BASP classification for hair loss is less accurate and harder to use but could still be a viable option.

Polish doctors find performance-enhancing substances unethical and want more knowledge to combat doping in sports.

More unbiased research is needed to improve androgenetic alopecia care.